Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

Core Insights - Scinai Immunotherapeutics Ltd. will showcase its innovative inflammation and immunology product pipeline and CDMO services at the BIO-Europe 2024 conference in Stockholm, Sweden from November 4-6, 2024 [1] Company Overview - Scinai Immunotherapeutics Ltd. specializes in inflammation and immunology biological products and offers CDMO services through its Scinai Bioservices unit [1][4] - The company has two business units: one focused on developing biological therapeutic products using nanosized VHH antibodies (NanoAbs) and the other providing CDMO services to early-stage biotech companies [4] Conference Participation - CEO Mr. Amir Reichman and CTO Dr. Dalit Weinstein-Fischer will hold meetings with prospective clients for CDMO services, potential pharma partners for co-development of NanoAbs, and investors interested in SCNI's value proposition [2] - Scinai will be available at exhibitor booth 150 to showcase its CDMO services throughout the conference [3]